SEC Form 8-K Summary
Business Context and Reporting Period
The filing is by Priveterra Acquisition Corp., a SPAC, not AEON Biopharma, Inc. The filing concerns the period ended March 31, 2021 and reports events occurring in May and June 2021. The filing date is June 4, 2021, although the reported event date is stated as May 25, 2021.
Key Financial and Accounting Matters
- The SEC Staff Statement on SPAC warrants concluded that certain warrant provisions require liability classification at fair value rather than equity classification.
- Priveterra had previously classified its public and private placement warrants as equity. It was evaluating the accounting impact and had not completed its March 31, 2021 Form 10-Q.
- The filing does not provide revenue, profit, cash flow, margins, debt, cash, liquidity, warrant fair values, or other financial statement amounts.
Material Changes and Listing Status
- The Company filed a Form 12b-25 on May 17, 2021 because it could not timely file the March 31, 2021 Form 10-Q.
- Nasdaq notified the Company that its failure to timely file the Form 10-Q violated Nasdaq Listing Rule 5250(c)(1).
- The securities were expected to continue trading on Nasdaq immediately, subject to compliance with other listing requirements.
Outlook, Risks, and Unusual Items
- The Company stated that it was working to complete and file the Form 10-Q as soon as reasonably practicable.
- It had 60 calendar days from receipt of the Nasdaq notice, until July 26, 2021, to submit a compliance plan.
- If Nasdaq accepted the plan, it could grant an additional period of up to 180 calendar days from the Form 10-Q due date, potentially extending compliance to November 22, 2021.
- Reclassification of warrants as liabilities could create material earnings volatility because changes in fair value would be recognized in earnings.
Investor Verification Items
- Verify the correct registrant: the supplied filing identifies Priveterra Acquisition Corp., while the request metadata identifies AEON Biopharma, Inc.
- Review the subsequently filed March 31, 2021 Form 10-Q for warrant classification, fair values, restated or revised financial statements, and any earnings impact.
- Confirm whether the Company submitted a Nasdaq compliance plan and whether Nasdaq granted an extension or imposed further listing conditions.
- Reconcile the filing’s dates: the notice was described as received May 28, 2021, while the press release and filing were dated June 4, 2021.